ESMOFIR/ESHI Satellite Symposium 2017

Start:

Sat, 8 Apr 2017, 09:00

End:

Sat, 8 Apr 2017, 05:00

Website:

http://www.esmofir.org/

Venue:

Exhibit

Symposia

Workshops

Organiser

Sponsor

Course Description

This course is aimed at radiologists, nuclear medicine physicians and researchers in medical imaging who want to update their knowledge on state-of-the-art hybrid medical imaging. The programme includes basics on hybrid imaging techniques, both on PET-CT and PET-MRI, expanding on the technical background and tracers, but will also give a broad overview on dedicated clinical applications such as hybrid imaging in oncology, cardiovascular imaging or brain imaging. The expert faculty comprises nuclear medicine physicians and radiologists who will provide a series of lectures describing indications and advances in hybrid imaging. Concluding, this course will provide a broad overview of the latest developments in hybrid imaging, as well as a good networking opportunity.

Learning Objectives

• to learn about imaging techniques, protocols and artefacts in hybrid imaging
• to understand the indications, limitations and added value of hybrid imaging in various entities
• to learn about systematic image evaluation of hybrid imaging
• to get a basic knowledge of tracers and radiopharmaceuticals for hybrid imaging

General Information

Date:
Saturday 8 April 2017

Time:
09.00h – 17.00h

Symposium Venue:
Max Planck Institute for Metabolic Research
Gleueler Str. 51, Cologne – just a short walk away from the EMIM venue

Symposium Organizer/Chair
Konstantin Nikolaou, Tubingen/DE

	early	….	late
Regular Non-Member*…..	150,00 €		300,00 €
Regular Member*	100,00 €		200,00 €
Junior Non-Member*	80,00 €		160,00 €
Junior Member*	80,00 €		100,00 €

Deadline for early bird registration: 14 February 2017
*ESMOFIR and ESMI members are eligible for the reduced member fee

Register Online!


09:00-10:30 Hybrid Imaging in Oncology I

09:00-09:30	Hybrid Imaging – What is it? Thomas Beyer, Vienna/AT
09:35-10:05	Novel tracers for hybrid imaging: pearls & pitfalls FDG and beyond Luigi Aloj, Cambridge/UK
10:05-10:30	Discussion

11:00-12:30 Hybrid Imaging in Oncology II

11:00-11:35	Therapy monitoring and criteria-based reporting in hybrid imaging Clemens Cyran, Munich/DE
11:35-12:05	Hybrid imaging and radionuclide therapy: theranostics alive Niklaus Schäfer, Lausanne/CH
12:05-12:30	Discussion

13:30-15:00 Hybrid Imaging: Cardiac and Brain

13:30-14:05	Hybrid imaging in cardiovascular diseases Matthias Gutberlet, Leipzig/DE
14:05-14:40	Hybrid imaging of the brain: dementia, tumors and beyond Alexander Drzezga, Cologne/DE
14:40-15:00	Discussion

15:30-17:00 Special Focus MR/PET: prostate and pediatrics

15:30-16:05	Hybrid imaging of the pelvis Lale Umutlu, Essen/DE
16:05-17:00	Hybrid imaging: pediatric indications Konstantin Nikolaou, Tübingen/DE